Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to payments for medical devices, including complexity adjustment criteria. Issues related to Most Favored Nation drug pricing.
2026 · 3rd Quarter (July 1 - Sep 30)
SMITH & NEPHEW, INC.
Filed by THE NICKLES GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- THE NICKLES GROUP, LLC
- Client
- SMITH & NEPHEW, INC.
- Filing UUID
- 825226d1-8de8-4c04-8c87-08db4f67c62a
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitor OECD negotiations related to Pillar II global minimum tax.
Literal federal measure citations: H.R. 1
Monitored issues related to price transparency.
Monitored issues related to tariffs. Issues related to the Section 301 forced labor investigation.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.